Provided by Tiger Trade Technology Pte. Ltd.

Merck

111.90
-2.7200-2.37%
Post-market: 111.950.0500+0.04%19:59 EDT
Volume:7.06M
Turnover:791.03M
Market Cap:277.74B
PE:15.37
High:114.03
Open:113.74
Low:111.50
Close:114.62
52wk High:125.14
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.69
T/O Rate:0.28%
Dividend:3.24
Dividend Rate:2.90%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:36.88%
ROA:12.04%
PB:5.28
PE(LYR):15.37

Loading ...

Earning Preview: Merck & Co., Inc. this quarter’s revenue is expected to increase by 3.53%, and institutional views are Neutral

Earnings Agent
·
Apr 23

Is Merck (MRK) Still Attractive After A 40% One Year Share Price Gain

Simply Wall St.
·
3 hours ago

Preview -- Barron's

Dow Jones
·
Yesterday

Rpt-Merck & Co Inc - Announces Hsr Waiting Period Expired for Terns Acquisition on April 23, 2026

THOMSON REUTERS
·
Apr 24

Corrected-Merck & Co Inc - on April 7 Commenced Cash Tender Offer for Terns at $53.00 per Share (Adds Dropped Words 'on Apirl 7')

THOMSON REUTERS
·
Apr 24

BRIEF-Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals

Reuters
·
Apr 24

Merck HSR waiting period expires for Terns acquisition offer at USD 53 a share

Reuters
·
Apr 24

Merck & Co Inc - Commences Cash Tender Offer for Terns at $53.00 per Share

THOMSON REUTERS
·
Apr 24

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

THOMSON REUTERS
·
Apr 24

Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Apr 24

Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL

TIPRANKS
·
Apr 24

Analysts’ Top Healthcare Picks: Merck & Company (MRK), Regeneron (REGN)

TIPRANKS
·
Apr 23

Top Midday Stories: GE Vernova Shares Gain on Strong Q1 Earnings, Guidance; Vertiv Lifts Guidance After Q1 EPS, Revenue Beats, Shares Fall

MT Newswires Live
·
Apr 22

Labcorp Rolls Out Companion Diagnostic for Merck's Keytruda in Platinum-Resistant Ovarian Cancer

MT Newswires Live
·
Apr 22

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
Apr 22

Inhibrx’s cancer drug drawing interest from Merck, Ono, Reuters says

TIPRANKS
·
Apr 22

Merck's Enflonsia Approved in UK to Prevent Respiratory Syncytial Virus in Infants

MT Newswires Live
·
Apr 22

Inhibrx up 39% at $117 after report of interest from Merck in cancer assets

TIPRANKS
·
Apr 22

Merck, Rivals Show Interest in Inhibrx's Experimental Cancer Drug, Reuters Reports

MT Newswires Live
·
Apr 22

Merck & Co Inc - Multi-Year Investment Valued at up to $1 Bln to Deploy Agentic Platform

THOMSON REUTERS
·
Apr 22